Article
Gutting it Out: Developing Effective Immunotherapies for Patients With Colorectal Cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) - 1 Jan 2000
Mendonça Gorgulho Carolina, Krishnamurthy Anuradha, Lanzi Anastasia, Galon Jérôme, Housseau Franck, Kaneno Ramon, Lotze Michael T
Abstract excerpt
Risk factors for colorectal cancer (CRC) include proinflammatory diets, sedentary habits, and obesity, in addition to genetic syndromes that predispose individuals to this disease. Current treatment relies on surgical excision and cytotoxic chemotherapies. There has been a renewed interest in immunotherapy as a treatment option for CRC given the success in melanoma and microsatellite instable (MSI) CRC....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
